Not yet recruitingPhase 4NCT07287371

Sucrosomial Vs Intravenous Iron for Preoperative Anemia

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Rochester
Principal Investigator
Michael P Eaton, MD
University of Rochester
Intervention
Treatment with oral sucrosomial iron(drug)
Enrollment
75 target
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Collaborators

Pharmanutra S.p.a.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07287371 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials